The purposes of this study are to identify temporal trends and risk factors for new HIV infection in injecting drug users who are currently HIV negative but remain at high risk. This will be done by following a cohort of 1,000 HIV negative drug users at six month intervals for 3 years. This study will allow the evaluation of the factors associated with behavior change over time in this high risk population. It will also allow an evaluation of the field effectiveness of such interventions as drug treatment, needle exchange, needle disinfection and educational programs to reduce high risk behavior in order to prevent HIV infection in a population of drug users in Baltimore, who currently have a 4% annual incidence of HIV infection. In addition, morbidity and mortality rates in this population will be assessed and compared with an HIV-positive population being followed in the same clinic. This will allow evaluation of which illnesses in this population are HIV-related. The interaction between HIV and other common infections in this cohort, such as hepatitis B and C, tuberculosis, HTLV-II and pneumococci will be evaluated. This study will allow the identification of HIV seroconverters soon after they become infected. Detailed virological and immunological studies among recent HIV seroconverters will allow a better understanding of the early natural history of HIV infections in this population, in order to design intervention strategies to prevent rapid progression to AIDS. The proportion of AIDS cases in the United States among drug users and their children and sexual contacts is increasing. Control of the AIDS epidemic in the United States requires a better understanding of the current incidence and risk factors for HIV infection in this critical population.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA008004-05
Application #
2458395
Study Section
Special Emphasis Panel (SRCD (24))
Project Start
1993-09-30
Project End
1999-07-31
Budget Start
1997-08-01
Budget End
1998-07-31
Support Year
5
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Smit, E; Crespo, C J; Semba, R D et al. (2006) Physical activity in a cohort of HIV-positive and HIV-negative injection drug users. AIDS Care 18:1040-5
Smit, Ellen; Semba, Richard D; Pilibosian, Erin et al. (2005) Body habitus in a cohort of HIV-seropositive and HIV-seronegative injection drug users. AIDS Patient Care STDS 19:19-30
Thio, C L; Nolt, K R; Astemborski, J et al. (2000) Screening for hepatitis C virus in human immunodeficiency virus-infected individuals. J Clin Microbiol 38:575-7
Tang, A M; Smit, E; Semba, R D et al. (2000) Improved antioxidant status among HIV-infected injecting drug users on potent antiretroviral therapy. J Acquir Immune Defic Syndr 23:321-6
Thomas, D L; Astemborski, J; Vlahov, D et al. (2000) Determinants of the quantity of hepatitis C virus RNA. J Infect Dis 181:844-51
Villano, S A; Vlahov, D; Nelson, K E et al. (1999) Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 29:908-14
Inglesby, T V; Rai, R; Astemborski, J et al. (1999) A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use. Hepatology 29:590-6
Wang, Z; Lyles, C M; Beyrer, C et al. (1998) Diversification of subtype E human immunodeficiency virus type 1 env in heterosexual seroconverters from Northern Thailand. J Infect Dis 178:1507-11
Thomas, D L; Vlahov, D; Alter, H J et al. (1998) Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J Infect Dis 177:539-42
Wang, Y M; Ray, S C; Laeyendecker, O et al. (1998) Assessment of hepatitis C virus sequence complexity by electrophoretic mobilities of both single-and double-stranded DNAs. J Clin Microbiol 36:2982-9

Showing the most recent 10 out of 16 publications